1. Home
  2. INDI vs DBVT Comparison

INDI vs DBVT Comparison

Compare INDI & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$3.62

Market Cap

688.9M

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.25

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
DBVT
Founded
2007
2002
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.9M
769.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INDI
DBVT
Price
$3.62
$19.25
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$6.25
$31.75
AVG Volume (30 Days)
2.9M
763.5K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$217,396,000.00
$5,502,000.00
Revenue This Year
$1.91
$1,768.71
Revenue Next Year
$30.15
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$2.93
52 Week High
$6.05
$26.19

Technical Indicators

Market Signals
Indicator
INDI
DBVT
Relative Strength Index (RSI) 38.83 57.63
Support Level $3.59 $18.46
Resistance Level $3.95 $22.89
Average True Range (ATR) 0.22 1.65
MACD -0.03 -0.07
Stochastic Oscillator 5.21 30.39

Price Performance

Historical Comparison
INDI
DBVT

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: